Voxtalisib Hydrochloride

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameVoxtalisib Hydrochloride
Drug Alias Name伏他利塞Voxtalisibum沃他利司voxtalisibXL-765 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionmTOR Complex 2 inhibitorsPhosphatidylinositol 3 kinase alpha inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2Phosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[13] 

Other Information

ATC CodeN/A
Related LinksN/A